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The principle challenge of cell biology is to reveal the mecha-
nisms and inner workings of cells. In this quest, cells are more 
and more perceived as systems in which the dynamic interplay of 
a large number of components determines the output of many   
biological processes occurring in parallel. To characterize these 
processes and to reveal their underlying principles, one needs to 
evaluate the dynamic composition and localization of the molec-
ular components. All cellular processes involve proteins and their 
characterization has therefore drawn most interest over the years. 
However, it has been technically challenging to determine their 
abundance, modification state, and localization in a systematic 
way. In the absence of system-wide technologies, targeted ap-
proaches are currently used to measure the abundance and local-
ization of specific proteins of interest. These rely on the availability 
of antibodies or epitope-tagged versions of the proteins to detect 
them by Western blot or microscopy. These workhorse techniques 
of cell biologists have allowed for the extensive characterization 
of many cellular processes. However, they often just open a small 
window into the complex world governing the organization of the 
cell and highlight only a small part of a large interconnected net-
work of functionally and physically interacting proteins.
For these reasons, there is a great need for techniques that 
allow the unbiased analysis of cellular compositions under chang-
ing conditions. A great breakthrough in this direction was the   
advent of microarrays, which enable the global quantification   
of gene expression. By default, mRNA quantification was also 
used as a proxy for measuring changes of protein abundance.   
Although this has resulted in a dramatic increase in our knowl-
edge of many cellular responses, studying protein levels directly 
would be advantageous because mRNA levels often do not cor-
relate well with protein abundance. This is because protein levels 
are determined by complex posttranscriptional processes, where 
every step in the life-cycle of a protein, from its synthesis to its 
degradation, is subject to regulatory input. Furthermore, the cen-
tral role of covalent protein modifications such as phosphoryla-
tion, acetylation, and glycosylation in cellular physiology as 
signals in information processing or as marks mediating pro-
tein associations is becoming increasingly appreciated. These 
modifications can also guide assembly of proteins into large 
macromolecular machines or instruct their localization to dif-
ferent organelles.
Among different possible approaches to study proteins, 
mass spectrometry (MS)–based proteomics is increasingly used 
to acquire the data important for understanding these processes. 
This technology is rapidly advancing and in modern proteomics 
it has essentially completely replaced previous tools such as 
two-dimensional gel electrophoresis. Within the field of MS-
based proteomics there is still a great variety of approaches and 
instruments, which can be confusing to the outsider. Here, we 
will mainly focus on one particular pipeline for high resolution 
MS-based proteomics that has proven robust and successful in 
our hands (Fig. 1). It can be used to derive the protein composi-
tion of a cell, to determine the members of proteins complexes, 
their architecture, the protein inventory of organelles, and the 
dynamics of these processes. It can also be readily combined 
with the analysis of the posttranslational modification state of 
proteins  and  their  dynamics.  However,  particularly  for  these 
more advanced applications, routine availability of proteomics 
in core facilities lags far behind pioneering studies reported in 
the literature (Bell et al., 2009). We hope that by focusing on one 
prototypical and robust workflow and exemplary applications, 
we will help to break down communication barriers between cell 
biologists and mass spectrometrists. Of course, different setups 
are also used very productively and alternative approaches exist 
for each step. We refer the reader to in-depth reviews on these 
topics here and below (Yates et al., 2005; Domon and Aebersold, 
The global analysis of protein composition, modifications, 
and dynamics are important goals in cell biology. Mass 
spectrometry (MS)–based proteomics has matured into an 
attractive technology for this purpose. Particularly, high 
resolution MS methods have been extremely successful for 
quantitative analysis of cellular and organellar proteomes. 
Rapid advances in all areas of the proteomic workflow, 
including sample preparation, MS, and computational 
analysis, should make the technology more easily avail-
able to a broad community and turn it into a staple meth-
odology for cell biologists.
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and Makarov, 2003; Scigelova and Makarov, 2006). The axial 
frequency of oscillations of the ions on this trajectory is propor-
tional to the square root of m/z. Because this frequency can be 
determined with high precision, the m/z is measured very accu-
rately. The Orbitrap also has very high mass spectrometric re-
solution, which is defined as the width of the peak at half height 
divided by the mass of the peak (and is therefore a dimension-
less number). Resolution commonly achieved in proteomics has 
risen within the last decade from just a few hundred in ion traps 
to 60,000 in current Orbitraps. Resolution is just as important in 
proteomics as it is in microscopy or in structural biology: with 
low resolution, peptides are effectively merged into common 
peaks, whereas high resolution allows the mass spectrometer 
to distinguish hundreds of thousands of different peptides from 
each other, a precondition for their accurate identification 
and quantification.
To determine the mass of an analyte, such as a peptide, 
from the m/z value, the charge state of the molecule is first de-
rived from the pattern of naturally occurring isotopes of different 
masses. This pattern is mainly caused by 
13C, which occurs with 
a low natural frequency (1% of the main 
12C isotope). Natural 
compounds have many carbon atoms and therefore show a family 
of peaks representing one, two, or more 
13C atoms integrated into 
the molecule. If the distance between peaks is one unit on the m/z 
scale, the charge of the peptide was one, if it was 0.5, then the 
charge was two.
2006; Jensen, 2006; Cravatt et al., 2007; Gingras et al., 2007; 
Trinkle-Mulcahy et al., 2008).
The language and principles of  
MS-based proteomics
MS is a way to accurately measure the weight of a molecule—
or more accurately its mass-to-charge ratio (m/z). Because mass 
analysis uses electromagnetic fields in a vacuum, molecules 
must first be electrically charged and transferred into the gas 
phase. In the pipeline that we describe here, both tasks are ac-
complished by electrospray ionization, which was developed by 
John B. Fenn and for which he shared the Nobel Prize in chem-
istry in 2002 (Fenn et al., 1989). Once in the gas phase, the m/z 
ratio of molecules is determined by their trajectories in a static 
or dynamic electric field. For example, a quadrupole mass filter   
can be set to only transmit ions of a particular m/z and by scan-
ning through a range of m/z values a mass spectrum can be ob-
tained. Other popular MS instrument types include quadrupole– 
time of flight (TOF) instruments, in which a quadrupole mass 
filter is coupled to a TOF analyzer that distinguishes the mole-
cules by their arrival times at a detector (Ens and Standing, 
2005). Alternatively, ions are captured by the field of an ion trap 
where they can be accumulated and manipulated for further 
analysis. In the described pipeline, we use a combination of a 
linear ion trap with an Orbitrap, in which ions circulate around 
a central, spindle-shaped electrode (Makarov, 2000; Hardman 
Figure  1.  A  prototypical  proteomics  pipe-
line.  Different  samples  are  processed  and 
fed into the proteomics pipeline, yielding dif-
ferent  results  depending  on  the  application. 
The  pipeline  consists  of  several  steps,  listed 
in the different panels: proteolytic digest (1), 
the separation and ionization of peptides by   
liquid chromatography (LC) coupled to electro-
spray ionization (2), their analysis by MS (3),   
fragmentation of selected peptides and analy-
sis of the resulting MS/MS spectra (4) and data   
analysis, including identification and quantifica-
tion of proteins from several detected peptides,   
as well as downstream bioinformatic analysis 
depending on the specific application (5). The 
peptide peaks in panel 3 represent isotopically 
labeled variants of the same peptide, in this   
case using the SILAC methodology. Their in-
tensity ratio is used for relative quantitation of 
proteins present in two samples. In the work-
flow described here, mass spectrometry is per-
formed with a linear ion trap–Orbitrap instrument   
(LTQ-Orbitrap) and computational proteomics is 
done within the MaxQuant framework. LC-MS/ 
MS, liquid chromatography coupled online to 
mass spectrometry; MS, mass spectrometry; 
MS/MS, tandem mass spectrometry; PTM, post-
  translational protein modification; Protein ID, pro-
tein identification; m/z, mass- to-charge ratio.493 Proteomics in cell biology • Walther and Mann
needs to detect proteins in complex mixtures. When proteins are 
digested to peptides, mixtures of even higher complexity are 
generated. The most robust method to reduce this complexity is 
one-dimensional SDS gel electrophoresis of proteins, followed 
by in-gel digestion by a protease (typically trypsin) and by ex-
traction of the resulting peptides from the gel (Shevchenko et al., 
1996). The alternative is to digest proteins in solution, avoiding 
the tedious gel separation and extraction step (Link et al., 1999; 
Washburn et al., 2001). The recently introduced filter-aided sample 
preparation (FASP) method combines the advantages of com-
plete solubilization in SDS with the advantages of in-solution 
digestion (Wiśniewski et al., 2009).
A key challenge in MS-based proteomics is to resolve and 
detect peptides in very complex mixtures. To this end, very low 
flow and narrow-bore liquid chromatography is coupled directly 
via electrospray to the mass spectrometer (LC-MS/MS). In this 
For proteomics, the first idea may 
be  to  characterize  proteins  by  their 
unique weight, which is a function of 
their  composition.  For  large  proteins 
the mass differences between different 
proteins  with  similar  composition  is 
small and entire proteins are anyway 
difficult to measure (this is the topic of 
a proteomic specialty called “top down 
proteomics”; McLafferty et al., 2007). 
Therefore, for most experiments, not 
the mass of entire proteins, but of pep-
tides derived from them by enzymatic 
cleavage,  is  measured  (“bottom  up 
proteomics”).  For  a  mixture  of  pep-
tides, this yields the MS-spectrum of 
mass-to-charge  ratios  plotted  against 
their mass spectrometric signal, the ion 
current. To determine the identity (i.e., 
sequence),  in  addition  to  the  exact 
mass  of  a  peptide,  it  is  fragmented 
along its backbone, usually by colli-
sion with an inert gas such as helium or 
nitrogen at low pressure (CID, colli-
sion induced dissociation). The result-
ing  spectrum,  called  an  MS/MS  (or 
tandem or MS
2) spectrum, is basically 
a list of m/z ratios for different frag-
ments  with  some  of  the  differences 
corresponding to the specific mass of 
one amino acid. In principle, connect-
ing the fragments with increasing size 
from the N terminus (b-ion series) or   
C terminus (y-ion series) allows for the 
deduction of the peptide sequence from 
the series of specific mass differences, 
each  corresponding  to  a  successive 
amino  acid  (de  novo  sequencing). 
However, the gas phase chemistry of 
decomposing  protonated  peptides  is 
quite intricate (Paizs and Suhai, 2005), 
and it is much easier and more common to match the measured 
fragment spectrum and peptide mass against a protein database 
with a search engine (Sadygov et al., 2004). For each protein, 
several peptides are measured and each contributes with a data-
base identification score, which should lead to highly confi-
dent identification. The most popular commercially available 
peptide search engines are Mascot (Perkins et al., 1999) and   
SEQUEST (Eng et al., 1994), whereas X!Tandem is an example of 
an open source program (Craig and Beavis, 2004). Despite the 
automated nature of searching database with MS data, the cell 
biologist should keep a critical attitude toward search results, 
and if possible, try to verify key identifications using the under-
lying primary data. This is particularly important in the case of 
low resolution spectra and when identifying modified peptides.
For most experiments, such as the determination of the 
proteome composition of an organelle or a protein complex, one 
Glossary of terms:
Liquid chromatography coupled online to mass spectrometry (LC-MS): Liquid chromatography by 
HPLC and usually reverse-phase chromatography, directly injecting samples via electrospray ioniza-
tion into a mass spectrometer for analysis during the chromatographic run.
Electrospray ionization: Analyte molecules such as peptides are dissolved in liquid that passes 
through a needle at high electric potential. The applied voltage causes the liquid to disperse into 
small, highly charged droplets, which evaporate and transfer the analyte molecules into atmosphere 
in an ionized form (usually by multiple protons). From here they are transferred into the vacuum of 
a mass spectrometer.
Time of flight mass analyzer (TOF): Mass analyzer where the m/z is determined by the time ions 
need to travel through an electric field. Due to the pulsed nature of the measurement, this type of an-
alyzer was most often coupled to matrix-assisted laser desorption (MALDI) of peptides, where a 
pulse laser leads to the release and ionization of peptides from a dried mixture of sample and ma-
trix. Today, it is also frequently used with electrospray in hybrid mass spectrometers of a quadru-
pole–time of flight format.
Linear ion trap–Orbitrap: A hybrid mass spectrometer consisting of a combination of a linear ion trap 
with an Orbitrap analyzer. The Orbitrap is a type of Fourier transform (FT) ion trap mass analyzer de-
veloped by A. Makarov where the ions oscillate along and around a central spindle. The square root 
of the m/z of trapped ions is proportional to the frequency of oscillations along the axis, which can be 
measured with very high precision. In Fourier transform mass spectrometers, the frequencies of the dif-
ferent components of the spectrum are transformed by a Fourier transform to yield the mass spectrum.
Collision-induced dissociation (CID): Fragmentation of peptide ions by energy acquired during colli-
sions with a chemically inert gas. In ion tap instruments, CID is most often performed by an auxiliary, 
resonating electric field that specifically excites the ions with the targeted mass-to-charge ratio.   
In quadrupole–time of flight (TOF) instruments, the kinetic energy is acquired by acceleration of 
peptides into a collision chamber containing the inert gas at a low pressure.
Stable isotope labeling by amino acids in cell culture (SILAC): SILAC is one of the metabolic labeling 
techniques in quantitative proteomics. Usually “heavy” 
13C- and 
15N-labeled forms of lysine, argi-
nine, or both are incorporated in a cell line or organism using metabolic labeling. In the MS analy-
sis,  these  heavy  amino  acids  are  distinguished  from  their  light,  unlabeled  counterparts  by  a 
characteristic mass shift. Note that these are nonradioactive forms of the amino acids.
iTRAQ: Quantitative proteomics technique that uses isobaric tags to chemically modify sample and 
control proteins. Peptides derived from these proteins can be distinguished via low mass reporter 
ions in their fragmentation spectra. The ratio of the reporter ions indicates the relative amounts of a 
peptide in each sample.
Single reaction monitoring (SRM) and multiple reaction monitoring (MRM): Specialized MS tech-
nique in which one quadrupole mass analyzer is set to transmit a peptide precursor ion of choice, 
a second quadrupole functions as a collision chamber (see CID), and a third quadrupole is set to a 
previously determined fragment mass of the peptide to be monitored. In SRM, a single transition is 
probed but to increase specificity of this technique it is more common to measure 3 to 8 transitions 
for each targeted peptide (MRM).
Protein correlating profiles (PCP): The localization of a protein in a specific organelle is determined 
by quantitatively comparing its abundance in the fractions of a purification with the behavior of 
marker proteins for that organelle.JCB • VOLUME 190 • NUMBER 4 • 2010   494
in order to understand the systems’ response to receptor stimula-
tion, changes of modifications over time should be quantified.
From an MS perspective, all these challenges necessitate 
the quantification of the relative abundance of peptides in differ-
ent samples. Comparing two protein complexes or large assem-
blies, such as the nucleolus, requires knowing the relative 
abundance  of  peptides  derived  from  proteins  present  in  two 
preparations, whereas elucidation of signal response requires 
measuring changes in the levels of phosphopeptides. Several ap-
proaches have been developed to tackle this problem. Mostly, 
we will focus here on two technologies that are frequently used 
and that can be combined seamlessly with the analysis pipeline 
described: isotope labeling and label-free quantification. In one 
of the metabolic labeling approaches, proteins fully incorporate 
“heavy”, nonradioactive isotope-containing amino acids (stable 
isotope labeling with amino acids in cell culture [SILAC]; Ong 
et al., 2002) and are analyzed by high resolution MS. To this 
end, arginine and/or lysine that is labeled with 
13C atoms and/or 
15N atoms is fed to cells, which integrate these amino acids into 
all proteins in the course of several cell doublings. Digestion of 
these proteins with trypsin, which cuts after arginine or lysine, 
leads to peptides with a heavy amino acid at their C terminus. 
The heavy labeled proteome remains distinguishable from the 
“light” or normal labeled control proteome and the two can be 
combined at the level of cells or directly after lysis. This pre-
vents differences in sample preparation from influencing quanti-
fication accuracy. The resulting mixture contains SILAC peptide 
pairs recognizable by having the exact mass difference between 
the heavy and normal amino acids. The relative intensity of the 
peaks reflects the relative abundance of the proteins in the mix-
ture. Although SILAC was originally developed for work on cell 
lines, it has been extended to include microorganisms and entire 
mice and even to the very accurate quantification of the levels of 
thousands of proteins in human tumor biopsies (Krüger et al., 
2008; Geiger et al., 2010).
The alternative to metabolic labeling is chemical modifi-
cation of peptides by stable isotope–containing tags. The best-
known strategy to this end is called iTRAQ. It uses up to eight 
isobaric tags that react with primary amine groups of peptides. 
During MS analysis, the tags are fragmented into reporter groups 
of different mass for each tag. The intensity of the different re-
porter groups is then used to derive the relative abundance of the 
corresponding peptides and proteins in the starting mixture (Ross 
et al., 2004).
Besides stable isotope labeling, so-called “label-free” 
quantification is increasingly used (Old et al., 2005). The basic 
idea here is to align separate LC-MS/MS runs of peptide mix-
tures and to calculate differences in intensities of the same pep-
tides detected in each run. Although quantification using this 
methodology is less accurate than methods using isotope labels, 
it may be simpler than isotope-based methods and makes cell 
types accessible that are difficult or impossible to label with 
amino acids (Malmström et al., 2009; Luber et al., 2010). In ad-
dition to these two, a number of variations and alternative tech-
niques have been developed that are reviewed in detail elsewhere 
(Ong and Mann, 2005; Bantscheff et al., 2007; Wilm, 2009).   
As an example, chemical dimethyl labeling of peptides can be 
mode, the sample is analyzed continuously as it elutes from an 
HPLC column. If very deep coverage of the composition of the 
sample is desired or if specific peptides should be enriched, e.g., 
modified by phosphorylation, an additional separation step,   
often using strong cation exchange (SCX), is used before analyz-
ing the samples. Additional fractionation is only seldom applied 
because the number of samples that need to be measured multi-
ply with each such step. In addition, classical biochemical 
fractionations, even if very vigorously performed, often yield 
fractions overlapping in composition. For MS, such additional 
fractionation steps often do not outweigh the increased analysis 
time. Instead, the very high mass accuracy and resolution of 
modern MS analyzers is used to distinguish between closely 
spaced peaks in spectra. In many proteomics applications the 
combination of such high resolution MS with good HPLC sepa-
ration yields peptide spectra sufficiently well resolved for a 
comprehensive detection of proteins present in a sample.
In the analysis pipeline described here, an MS spectrum is 
obtained roughly every 2 s. From this, typically up to 10 peptides 
are selected for fragmentation and the MS/MS spectrum is re-
corded from each simultaneously with the MS spectrum. Over 
the usual 2 h chromatography run, an enormous amount of data 
are therefore collected and its analysis is a severe challenge for 
proteomics. Many efforts have been made to automate parts or 
all of the computational tasks associated with proteomics. One 
of the earliest was the trans-proteomic pipeline (Deutsch et al., 
2010), but there are many others, such as msInspect (Bellew   
et al., 2006) or Census (Park et al., 2008).
In the pipeline described here, all computational proteomics 
tasks are handled by the freely available MaxQuant environment 
(Cox and Mann, 2008), which is equipped with its own search 
engine called Andromeda (also freely available) as well as with 
visualization tools that allow verification of database identifica-
tions. Analysis in MaxQuant results in much-improved mass ac-
curacy and percentage of successfully identified MS/MS spectra 
(typically >50%). In addition to the computational proteomics 
analysis packages, many of the established tools for the analysis 
of microarray gene expression data within the Bioconductor/R 
software are applicable to the downstream interpretation of pro-
teomics datasets (Kumar and Mann, 2009).
Quantitative proteomics
Most often it is more important to determine how protein levels 
change from one condition to the next than it is to know just 
whether a protein is present or not. Relative abundance of pro-
teins between two cellular states, for example between control 
and specific perturbation, is therefore a crucial variable in cell 
biological experiments. The goal of biochemical purifications of 
organelles  or  protein  complexes  is  most  often  to  determine 
whether a protein is enriched in the purified fraction, as opposed 
to being present merely as a contaminant. The most interesting 
question may be how the composition of an organelle or a pro-
tein complex changes under different conditions, or in different 
cell types. Similarly, changes in abundance of posttranslational 
modifications are important, particularly for studying cellular 
signaling, as the level rather than just the presence of many mod-
ifications transmit crucial information in the cell. For example, 495 Proteomics in cell biology • Walther and Mann
The remaining proteins only detected in the target fraction are 
enriched in components of the organelle of interest. Such a strat-
egy  was  used  to  characterize  nuclear  envelope  components 
(Schirmer et al., 2003). However, limitations of this approach in-
clude that results depend not only on proteins in the target organ-
elle, but also on those in the control. For the case of the nuclear 
envelope, the choice of endoplasmic reticulum (ER) as a control 
is straightforward. For other organelles, such as mitochondria, it 
is less so. In addition, in very complex fractions only subsets of 
the proteins may be detected and this detection may be partly sto-
chastic (because the same peptides are not always picked for   
sequencing by the mass spectrometer). This could lead to false-
positive organellar assignments. Conversely, if one achieves to 
detect all proteins in each fraction, the subtraction list may miss 
many true hits as they are likely present in minor amounts as con-
taminants in the control fraction.
Fortunately, this problem of very many low abundant 
background proteins can be sidestepped using quantitative pro-
teomics, where not only the identity, but also the abundance of 
proteins in a sample are determined. This information is then 
used to separate genuine members of organelles from copurify-
ing ones by their quantitative behavior during fractionation. In a 
crude form, which is nevertheless a large improvement on purely 
qualitative data reporting on the presence of proteins in a sam-
ple, the number of identified peptides of each protein in an or-
ganelle fraction or control are compared. These techniques are 
termed “spectral counting” (Liu et al., 2004; Lu et al., 2007) or 
“exponentially modified peptide abundance index” (emPAI; 
Ishihama et al., 2005), and are often built into proteomics data 
analysis pipelines. They are based on the principle that the likeli-
hood of identifying peptides of a given protein is correlated with 
the abundance of the protein. True quantification of the signal in 
MS peaks is much more accurate than spectral counting and can 
be the basis of bioinformatic, statistical models that assign a 
probability for localization in the compartment or complex. For 
example, precise ratios of protein abundance can be obtained by 
mixing an organelle preparation with different SILAC-labeled 
control fractions enriched in different organelles. From these   
ratios a score that reflects the likelihood of localization in each 
organelle can be developed. For each such combination, one   
expects a bimodal distribution with proteins truly localized in 
the target organelle distributing around one mode of ratios and 
contaminants forming a second mode. The localization score is 
developed from a Bayesian model assuming overlapping normal 
distributions of measured ratios. This methodology is particu-
larly suited for samples where stringent purification is either not 
possible due to limited sample availability or not desirable be-
cause many associated proteins are expected to be lost during 
purification. We have applied this strategy to crude purifications 
of mitochondria from brown and white adipose tissue, where it 
revealed significant differences both in the presence and abun-
dance of mitochondrial proteins (including isoforms) between 
these tissues (Forner et al., 2009).
A second quantitative approach to organellar proteomics 
is to determine not just abundance of proteins in the target frac-
tion, but to follow their behavior during the purification. The 
basic idea is that proteins that are together in one organelle 
performed economically with isotopically light or heavy re-
agents (Hsu et al., 2003; Boersema et al., 2009). As usual with 
chemical techniques in proteomics, it is important to ensure that 
reactions go to completion. Last not least, if quantification of 
only a selected subset of proteins is desired, peptides of these 
proteins can be targeted by a technique called multiple reaction 
monitoring, or MRM. This requires specialized “triple quadru-
pole” mass spectrometers, which consist of a selection quad-
rupole for the precursor ion, a collision cell quadrupole, and a 
selection quadrupole for the fragments. They are set to exclu-
sively monitor predetermined precursor-to-fragment transitions 
in rapid succession. In this way the presence and—if an isotope-
labeled synthetic peptide analogue is used, the quantity of se-
lected peptides—can be monitored (Wolf-Yadlin et al., 2007; 
Kitteringham et al., 2009; Unwin et al., 2009).
Analysis of cellular composition  
and architecture
MS-based proteomics is now closing the gap to gene expression 
analysis, which measures the abundance of messenger RNAs. 
We have recently quantified haploid against diploid yeast using 
the SILAC technology. Essentially all proteins that were found 
to be expressed by both TAP and GFP tagging of all yeast open 
reading frames (Ghaemmaghami et al., 2003; Huh et al., 2003) 
were identified. This demonstrates that complete proteomes can 
be obtained by MS-based proteomics (de Godoy et al., 2008). 
MRM has been used on selected proteins in yeast and has identi-
fied proteins down to an estimated 43 copies per cell (Picotti   
et al., 2009). Together with MRM of isotope-labeled reference 
peptides, the absolute abundance of some proteins was deter-
mined in that study. This approach has been combined with 
cryo-tomography to measure the copy number of cellular struc-
ture of the pathogen Leptospira (Malmström et al., 2009). The 
abundance of other cellular proteins can then roughly be approx-
imated by the added peptide intensity for each protein.
All cells, and particularly eukaryotic ones, are character-
ized by a high degree of spatial organization of biochemical 
reactions. Therefore, in addition to the inventory of a cell, the   
localization of proteins is an important second dimension of 
knowledge. Classically, two approaches are taken to answer this 
question: microscopy to detect proteins in situ, and biochemical 
fractionation of cells in organelles and proteins complexes.
Fractionation approaches are now increasingly combined 
with MS-based proteomics to detect and measure proteins in pu-
rified organelles (Yates et al., 2005). Despite the success of early 
organellar proteomics (Neubauer et al., 1997; Rout et al., 2000), 
researchers soon realized that in other studies often too many   
organellar proteins were being identified. In fact, the principle 
problem of biochemical purifications of organelles is that not all 
proteins in a fraction are bona fide constituents of the investigated 
organelle, but might instead be contaminants, copurifying with 
the organelle. This is particularly a problem for modern MS tech-
niques  with  extremely  high  sensitivity.  The  simplest  solution   
to this problem is “subtractive proteomics”, in which the inven-
tory of both a target and a related fraction missing the structure   
of interest are analyzed. Each proteomic characterization leads   
to an inventory list, which are “subtracted” from each other. JCB • VOLUME 190 • NUMBER 4 • 2010   496
were later described to cause genetic diseases when mutated. 
These ciliopathies have the common feature that function of 
the basal body, the centrosome analogue in post-mitotic cells, 
is impaired.
In an interesting application of quantitative proteomics to 
the remodeling of nuclear organelles, Boisvert et al. (2010) mea-
sured the quantitative fraction of each of 2,000 proteins in the 
cytosol, nucleus, and nucleolus, which they term “spatial pro-
teomics.” They then studied the redistribution of those proteins 
as a function of a perturbation, in this case chemically induced 
DNA damage. The same group also found distinct redistribution 
of specific nucleolar proteins upon infection of cells with adeno-
virus (Lam et al., 2010).
In addition to organelles, protein complexes are a funda-
mental unit of cellular organization. In principle, the same con-
siderations concerning the background of contaminant proteins 
apply to both organelle and protein complex purifications. Dif-
ferences in the analysis stem mostly from different purification 
strategies used for either application. Most often, protein com-
plexes are purified by affinity chromatography of a tagged sub-
unit of the complex. In contrast to organelle purifications that 
differ strongly for each target, protocols for complex purification 
should also copurify with the same abundance pattern over frac-
tions of the purification. These abundance profiles are compared 
and grouped for similarity with known markers of the target   
organelle. The resulting protein correlation profiles (PCPs)   
resemble the calculation of purification factors in classical   
biochemistry because they reveal not only which proteins are 
present in the target fraction, but which proteins co-enrich there 
(Fig. 2). Particularly useful for this method are data derived 
from purification by density gradients where the profiles of pro-
teins over the length of the gradients are quantified. Applied to 
centrosome purifications, this led to the recognition of the cen-
trosomal localization of many proteins previously not known to 
be located there (Andersen et al., 2003). When used in a SILAC 
format a batch of cells is labeled and used to isolate a target   
organelle, e.g., by density gradient centrifugation. This labeled 
sample is then mixed into each fraction of a second purification 
from unlabeled cells. For each protein, a profile of ratios identi-
fied throughout the fractions is then calculated. Similar to their 
behavior in profiles resulting from other quantitation methods, 
proteins strongly enriched in the target fraction will have a peak 
of the ratio only there. Conversely, if a protein is a contaminant, 
it will peak elsewhere, depending on its main localization in the 
cell. Another strategy with a similar aim is localization of or-
ganelle proteins by isotope tagging (LOPIT). This technology 
was first demonstrated using principle component analysis of 
the correlation patterns of proteins in different fractions to re-
veal membrane proteins residing in the ER or Golgi apparatus 
of plant cells (Dunkley et al., 2004; Tan et al., 2009).
The literature contains a wide diversity of organellar pro-
teomics datasets, ranging from stringent quantitative experimen-
tal designs with very low error rates to purely qualitative lists of 
proteins in which clearly the majority of proteins do not belong 
to the organelle under investigation. So how can the quality of 
organellar assignment be assessed? Currently there is no stan-
dard answer to this question, but comparison to data generated 
independently using different methods may offer valuable posi-
tive controls. For example, an atlas of subcellular localization of 
GFP-tagged fusion proteins can be used to confirm datasets gen-
erated for the yeast Saccharomyces cerevisiae (Huh et al., 2003). 
It may also be useful to compare data obtained for different 
model systems with each other. The nucleolar proteome derived 
from HeLa cells, for instance, contained homologues of 87% of 
the yeast nucleolar proteins, implicitly validating both datasets 
(Andersen et al., 2005).
Gene ontology (GO) terms are defined sets of concepts in 
cellular components, molecular functions, and biological pro-
cesses, as well as the relationships between them. These terms 
describe different aspects of protein characteristics, such as its 
localization, biochemical activity, and biochemical context. As 
an easily accessible summary of information, they are often 
used to assess the quality of a dataset (Ashburner et al., 2000). 
In addition, data from other sources, such as genetic or RNAi 
screens is increasingly used to benchmark results from compre-
hensive proteomics experiments, assuming that knock-down of 
proteins is likely to result in a phenotype related to the function 
of the organelle where it is located. In this way, many proteins 
found by protein correlation profiling to localize to centrosomes 
Figure 2.  Organellar proteomics. Organelles are purified using fraction-
ation of a cell extract, e.g., by gradient centrifugation. The resulting gra-
dient (gray box) is divided into samples and these resulting fractions are 
analyzed using the proteomics pipeline. Comparison of the abundance 
profiles of proteins (bottom panel, green lines) throughout all fractions of 
the purification to the profile of known marker protein (bottom panel, red 
line) yields classes of proteins that cofractionate with the organelle of inter-
est (protein abundance marked with crosses), or that are present in the 
peak fraction for this organelle merely as a contaminant (protein abun-
dance marked with circles or triangles).497 Proteomics in cell biology • Walther and Mann
In a different type of experiment, turnover of proteins in 
the cell or a specific organelle can be measured. Analogously to 
pulse-chase experiments, heavy labeled amino acids are used for 
kinetic measurements. However, in proteomics cells are only 
pulsed. The proteome can be fully labeled with heavy amino   
acids followed by a switch to nonlabeled ones at the start of the 
experiment. The disappearance of the label is then a measure of 
the protein turnover rate (Beynon and Pratt, 2006).
can be standardized to a much higher degree. Similar to the case 
of organellar purification, the basic principle is to use quantita-
tive proteomics to distinguish background proteins that equally 
occur in the pulldown with the bait and in the control pulldown 
from specific binders that preferentially occur in the pulldown 
with the bait (Fig. 3; Blagoev et al., 2003; Ranish et al., 2003). 
For a number of purifications, the background can also be esti-
mated from a “bead proteome,” representing all proteins bound 
nonspecifically to the purification bead matrix, or from quantita-
tive proteomics comparing the affinity purification of a target 
complex with a mock purification (Trinkle-Mulcahy et al., 2008). 
Because affinity purification yields much higher purification fac-
tors and generally fewer contaminants than organelle enrich-
ments, label-free approaches are often easier for determination 
of specific interactors, but SILAC can equally be applied (Hubner 
et al., 2010). In either case, quantitation is essential to efficiently 
separate  true  binders  from  hundreds  of  background  proteins. 
When combined with labeled peptide standards, proteomics can 
also be used to determinate the stoichiometry of complexes (Wepf 
et al., 2009).
MS-based proteomics has been applied to determine the   
interactome of the yeast model organism, using genomically   
integrated tags for purification (Gavin et al., 2006; Krogan et al., 
2006). Initially in proteomics projects, stringent purification with 
tandem affinity purification (TAP) tags (Rigaut et al., 1999) was 
widely  used,  but  quantitative  methods  now  allow  reverting  to 
milder, single-step purification, increasing the chance to retain 
weak interactors. GFP is particularly useful as a purification tag 
because it allows for localization by fluorescence microscopy of 
the proteins of interest in the same cells where MS analysis is per-
formed (Shou et al., 1999; Cheeseman and Desai, 2005; Cristea   
et al., 2005). Highly efficient binders to GFP have been developed 
(Rothbauer et al., 2008).
In such systematic experiments, the availability of larger 
datasets is an advantage for analysis. Contaminants tend to be 
shared between many purification experiments. For yeast, where 
a number of independent genome-wide interactome studies are 
available, this wealth of information has already been used to   
integrate the data and develop an interaction map considering   
the statistical significance of a detected interaction (Collins et al., 
2007; Wang et al., 2009). However, similarly to the case of the 
organellar purifications discussed above, we recommend doing 
such filtering in a quantitative rather than a qualitative way.
Analysis of cellular dynamics
At the next level of analysis, addition of a time dimension will 
yield the dynamic properties of cellular systems. This is achieved 
by  quantitative  proteomic  comparison  between  different  time 
points. The same quantitative proteomics methods outlined above 
are applicable here. In such an experiment, the abundance of pro-
teins after a time interval of, for instance, a drug treatment, is 
compared with the starting abundance (Fig. 4). For example, tem-
poral analysis of protein flux out of an organelle was measured 
for the nucleolus. A large number of proteins was found to exit 
the nucleolus after inhibition of transcription with actinomycin D, 
but interestingly, disassembly of the entire structure was not   
observed (Andersen et al., 2005).
Figure 3.  Interaction proteomics. To detect specific binders to a tagged 
protein of interest (e.g., GFP, green sphere on target protein), abundance 
of potential interaction partners is compared with the abundance of the 
same protein from a mock purification expressing only untagged versions 
of the proteins. For example, extracts from “heavy” SILAC-labeled cells 
expressing tagged proteins (left) or control extracts (right) are subjected to 
affinity chromatography. The resulting eluates from target and mock puri-
fication are mixed and analyzed by the proteomics pipeline. Background 
binders are present in equal amounts in both purifications (circles in the 
plot), whereas proteins specifically binding to the bait have high ratios 
reflecting their specific enrichment from the heavy SILAC-labeled sample 
(rectangles in the plot).JCB • VOLUME 190 • NUMBER 4 • 2010   498
or antibody affinity chromatography, and this modification is   
detected by MS as a mass shift of the intact peptide and of the   
b- and y-fragment ions bearing the phosphorylated amino acid 
(Wepf et al., 2009).
Combined with quantitative approaches such as SILAC, 
these types of phosphoproteomics techniques enable the tempo-
ral analysis of signaling in a broad, system-wide fashion. Quan-
titation of the cellular phosphoproteome response to EGF 
treatment revealed a previously unimagined scope of the cellular 
response. The temporal dynamics also demonstrated that within 
one protein, different sites are often regulated with different ki-
netics (Olsen et al., 2006). Such types of analyses provide an   
unprecedented density of data for analysis although they are re-
stricted to specialized laboratories for the time being (Nita-Lazar 
et al., 2008; White, 2008; Boersema et al., 2009).
The analysis of posttranslational modifications is not lim-
ited to phosphorylation networks. Systems analysis of protein 
acetylation on lysines has recently identified more that 3,600 
acetylation sites. To reach this depth of coverage, acetylated 
peptides are enriched using immunoprecipitation by monoclo-
nal antibodies directed against acetylated lysines. Often, this 
modification occurs on large macromolecular complexes, which 
suggests that it might regulate these machines (Kim et al., 2006; 
Choudhary et al., 2009). Consistent with this notion, acetylation 
of metabolic enzymes in bacterial Salmonella cells led to the de-
tection of 191 acetylated sites and together with a study in human 
liver tissue highlights metabolic regulation by acetylation (Wang 
et al., 2010; Zhao et al., 2010). Likewise, MS-based proteomics 
is frequently used for the analysis of ubiquitination in which the 
Gly-Gly tag is detected as a modification of the substrate site   
after tryptic digestion, or for SUMOlylation analysis, in which 
case a larger cross-linked peptide is generated (Andersen et al., 
2009). Additionally, a wide variety of other modifications can be 
detected by MS and large-scale studies of many of them have   
already been undertaken (Witze et al., 2007).
Outlook
One trend in the future of cell biology is the application of un-
biased approaches to questions of cellular behavior. In this regard, 
MS-based proteomics is particularly attractive because it focuses 
on proteins, their localization, modifications, and interactions.   
It is now becoming available to a larger community. The rapid 
developments of instrumentation and informatics tools for pro-
teomics described here will facilitate this. However, large 
differences in the quality of data generated in proteomics projects 
still exist. Particularly, low resolution spectra can lead to mis-
interpretation of identifications, localization of modifications, and 
quantitation. Furthermore, in many experiments the trade-off be-
tween proteome coverage and the different conditions tested is 
still a limitation. While in-depth analysis, particularly of very 
complex samples, is still a difficult problem tackled mainly by 
expert laboratories, robust and reliable instrumentation increas-
ingly make MS-based proteomics a biochemical technique of 
choice. So far, it still requires considerable expertise and dedi-
cated personnel, but most cell biochemical approaches driven by 
proteomics outlined here are now accessible to all. Application of 
these methods in combination with biochemical techniques used 
The analysis of proteome dynamics is not restricted to 
analysis of organelles. Cellular responses to a change in external 
conditions are often mediated by signal transduction cascades in 
which the flow of information is represented by dynamic changes 
in the posttranslational modification of proteins. By far the best 
studied is phosphorylation of serines, threonines, and tyrosines. 
Phosphorylated peptides can be enriched up to 100-fold by metal 
Figure 4.  Time-resolved proteomics. To detect dynamic proteome changes 
after a change of conditions, the amount of proteins is followed over time 
after an initial treatment. For example, cells are treated with a stimulus at 
the beginning of the experiment and aliquots are analyzed in intervals 
either directly or after enrichment of organelles, protein complexes, or post-
translational modifications (PTMs) by the proteomics pipeline. Plotting the 
abundance of proteins or modifications over time results in a dynamic 
view of the abundance of proteins or specific modifications during the time 
course of the experiment, and may identify different phases of the response 
(e.g., immediate, early, and late response).499 Proteomics in cell biology • Walther and Mann
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